104 related articles for article (PubMed ID: 34510513)
1. Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study.
Gidener T; Yin M; Dierkhising RA; Allen AM; Ehman RL; Venkatesh SK
Hepatology; 2022 Feb; 75(2):379-390. PubMed ID: 34510513
[TBL] [Abstract][Full Text] [Related]
2. Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD.
Gidener T; Dierkhising RA; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Yin M; Allen AM
Hepatology; 2023 Jan; 77(1):268-274. PubMed ID: 35642504
[TBL] [Abstract][Full Text] [Related]
3. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
Semmler G; Yang Z; Fritz L; Köck F; Hofer BS; Balcar L; Hartl L; Jachs M; Stopfer K; Schedlbauer A; Neumayer D; Maurer J; Müllner-Bucsics T; Simbrunner B; Scheiner B; Trauner M; Mandorfer M; Reiberger T; Bauer DJM
Gastroenterology; 2023 Oct; 165(4):1041-1052. PubMed ID: 37442301
[TBL] [Abstract][Full Text] [Related]
4. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V; Kim BK; Yang K; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Quach NE; Tu X; Zhang X; Noureddin M; Allen AM; Loomba R
Gastroenterology; 2022 Oct; 163(4):1079-1089.e5. PubMed ID: 35788349
[TBL] [Abstract][Full Text] [Related]
5. Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography.
Kobayashi T; Iwaki M; Nogami A; Kawamura N; Honda Y; Ogawa Y; Imajo K; Yoneda M; Saito S; Nakajima A
J Gastroenterol; 2024 Jan; 59(1):56-65. PubMed ID: 37845417
[TBL] [Abstract][Full Text] [Related]
6. Role of magnetic resonance elastography in compensated and decompensated liver disease.
Asrani SK; Talwalkar JA; Kamath PS; Shah VH; Saracino G; Jennings L; Gross JB; Venkatesh S; Ehman RL
J Hepatol; 2014 May; 60(5):934-9. PubMed ID: 24362072
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of transient elastography in differentiation between porto-sinusoidal vascular liver disease and compensated cirrhosis.
Zhang G; Ma L; Fu L; Li M; He F; Feng L; Wang M; Jia J; Wang Y; Zhao X
Liver Int; 2023 Nov; 43(11):2513-2522. PubMed ID: 37614162
[TBL] [Abstract][Full Text] [Related]
8. The associations between fibrosis changes and liver-related events in patients with metabolic dysfunction-associated steatotic liver disease.
Lee HW; Kim KH; Ahn SH; Lee HC; Choi J
Liver Int; 2024 Jun; 44(6):1448-1455. PubMed ID: 38488679
[TBL] [Abstract][Full Text] [Related]
9. Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis.
Dallio M; Romeo M; Vaia P; Auletta S; Mammone S; Cipullo M; Sapio L; Ragone A; Niosi M; Naviglio S; Federico A
World J Gastroenterol; 2024 Feb; 30(7):685-704. PubMed ID: 38515952
[TBL] [Abstract][Full Text] [Related]
10. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
Thorhauge KH; Semmler G; Johansen S; Lindvig KP; Kjærgaard M; Hansen JK; Torp N; Hansen CD; Andersen P; Hofer BS; Gu W; Israelsen M; Mandorfer M; Reiberger T; Trebicka J; Thiele M; Krag A;
J Hepatol; 2024 Feb; ():. PubMed ID: 38428644
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria.
Ding D; Guo G; Cui L; Jia G; Wang X; Zhang M; Tian S; Zheng L; Liu Y; Hu Y; Xuan G; Yang J; Yang C; Sun R; Deng J; Guo C; Chen Y; Shang Y; Han Y
Hepatol Int; 2024 Feb; 18(1):206-215. PubMed ID: 37725332
[TBL] [Abstract][Full Text] [Related]
12. Increases and decreases in liver stiffness measurements are independently associated with the risk of liver-related events in NAFLD.
Gawrieh S; Vilar-Gomez E; Wilson LA; Pike F; Kleiner DE; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Kowdley KV; Hameed B; Tonascia J; Loomba R; Sanyal AJ; Chalasani N;
J Hepatol; 2024 May; ():. PubMed ID: 38762169
[TBL] [Abstract][Full Text] [Related]
13. An LSM Based Strategy is Comparable to HVPG Measurement to Predict Further Events in Patients with Cirrhosis with Variceal Bleeding as Their Index Decompensation.
Sharma S; Agarwal S; Saraya A
J Clin Exp Hepatol; 2023; 13(5):774-782. PubMed ID: 37693274
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
Kim BK; Bergstrom J; Loomba R; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Truong E; Yang JD; Noureddin M; Allen AM; Loomba R; Ajmera V
Hepatology; 2023 Dec; 78(6):1858-1866. PubMed ID: 37203233
[TBL] [Abstract][Full Text] [Related]
15. Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.
Loomba R; Huang DQ; Sanyal AJ; Anstee QM; Trauner M; Lawitz EJ; Ding D; Ma L; Jia C; Billin A; Huss RS; Chung C; Goodman Z; Wong VW; Okanoue T; Romero-Gómez M; Abdelmalek MF; Muir A; Afdhal N; Bosch J; Harrison S; Younossi ZM; Myers RP
Gut; 2023 Mar; 72(3):581-589. PubMed ID: 36750244
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis.
Berenguer J; Aldámiz-Echevarría T; Hontañón V; Fanciulli C; Quereda C; Busca C; Domínguez L; Hernández C; Vergas J; Gaspar G; García-Fraile LJ; Díez C; De Miguel M; Bellón JM; Bañares R; González-García J
Hepatology; 2024 Mar; ():. PubMed ID: 38452004
[TBL] [Abstract][Full Text] [Related]
17. Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients.
Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren Å; Nasr P; Shahnavaz A; Vessby J; Westin J; Önnerhag K; Hagström H
Liver Int; 2024 Apr; ():. PubMed ID: 38560775
[TBL] [Abstract][Full Text] [Related]
18. Liver stiffness and thrombin generation in compensated cirrhosis.
Dillon A; Egan K; Kevane B; Galvin Z; Maguire P; Ní Áinle F; Stewart S
Res Pract Thromb Haemost; 2019 Apr; 3(2):291-297. PubMed ID: 31011714
[TBL] [Abstract][Full Text] [Related]
19. A Three-Dimensional Digital Model for Early Diagnosis of Hepatic Fibrosis Based on Magnetic Resonance Elastography.
Liu Y; Liang T; Xing F; Hou W; Shang X; Li X
J Vis Exp; 2023 Jul; (197):. PubMed ID: 37677034
[TBL] [Abstract][Full Text] [Related]
20. Inflammation activity affects liver stiffness measurement by magnetic resonance elastography in MASLD.
Wei X; Qi S; Wei X; Qiu L; Du X; Liu Y; Xu H; Zhao J; Chen S; Zhang J
Dig Liver Dis; 2024 May; ():. PubMed ID: 38744558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
